Wed.Dec 16, 2020

article thumbnail

With trial plans, Novo wagers its diabetes drug can help treat Alzheimer's

Bio Pharma Dive

Similar diabetes drugs from Novo have shown signs of promise in treating dementia. The Danish biotech is now putting that hypothesis to the test.

Drugs 332
article thumbnail

Virtual ad boards

World of DTC Marketing

Pharma has adapted virtual ad boards which is essential for impact marketing. I’ve noticed, however, that some best practices for ad boards seem to be slipping. Here is a checklist. 1ne: “Let’s have an ad board.” The first question you need to ask is whether you really need an ad board. Ad boards should not be used to tell something you already know. 2wo : What’s our objective?

Marketing 180
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Gilead hands back some rights to key drug from Galapagos deal

Bio Pharma Dive

The drug, known as filgotinib, recently hit a setback in the U.S., prompting Gilead to lose confidence that it can gain approval or compete against rival medicines in rheumatoid arthritis.

Drugs 265
article thumbnail

ABPI chief exec on the UK industry’s learnings from COVID-19

pharmaphorum

The ABPI’s chief executive Dr Richard Torbett shares his views on how the industry has adapted to COVID-19 and explains why the post-pandemic future is looking bright for the UK industry. January 2020 would have been an interesting time for anyone to start a new job, but for Richard Torbett, who moved into the chief executive position at the ABPI after five years at the Association, it meant taking the helm of an organisation that quickly found itself on the frontline of global efforts to fight

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Pharmacquired: What a surprise deal does for AstraZeneca and Alexion

Bio Pharma Dive

The $39 billion tie-up between the two companies sparked questions about whether Alexion could have sold for more. Yet, it doesn't look like rival bidders stood in AstraZeneca's way.

242
242
article thumbnail

Surface Oncology, GSK Enter $815 Million Agreement to Advance Immunotherapy Agent

BioSpace

Surface Oncology has agreed to grant exclusive worldwide licensing rights to GlaxoSmithKline for the development and commercialization of Surface Oncology’s SRF813, a fully human IgG1 antibody and immunotherapy designed to treat cancer.

More Trending

article thumbnail

Thoughtful Gifts for Individuals with Cancer

Triage Cancer

At Triage Cancer we believe in sharing resources that might be helpful to the cancer community. Today, we introduce you to Mend Together. Keep on reading for some thoughtful gift ideas for the person in your life coping with cancer. . Most of us feel helpless when someone we care about is diagnosed with cancer. We want to say the right things, do the right things and make a difference — but don’t always know where to start. .

article thumbnail

Individuals with high ADHD-traits are more vulnerable to insomnia

Scienmag

Credit: Andreas Andersson Individuals with high ADHD-traits that do not meet the criteria for a diagnosis are less able to perform tasks involving attentional regulation or emotional control after a sleepless night than individuals with low ADHD-traits, a new study from Karolinska Institutet published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging reports.

article thumbnail

FDA backs Moderna COVID-19 shot ahead of emergency use vote

pharmaphorum

Moderna looks odds on to claim emergency use authorisation from the FDA for its COVID-19 vaccine this week, after the regulator published a report endorsing its safety and rating its efficacy at 94.5%. The document has been published just after the US started the rollout of Pfizer and BioNTech’s vaccine after it got an emergency green light last week, and ahead of an expert panel due to consider Moderna’s shot on Thursday.

article thumbnail

Four Potential Biotech Market Movers to Watch Going into 2021

BioSpace

As we eagerly look ahead to 2021, BioSpace spoke to four biotechs hoping to seize this opportunity in the first wave of COVID-19 vaccines and therapies – or make an impact in the second.

Marketing 106
article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Novo Holdings establishes rare bleeding disorder firm Hemab

Pharma Times

New company will focus on developing bispecific antibodies for rare bleeding disorders

Antibody 133
article thumbnail

Months of Work Hang in the Balance as Moderna’s COVID-19 Vaccine Awaits AdComm Vote

BioSpace

A critical vote is set to take place today amongst those on a U.S. Food and Drug Administration advisory panel in regard to the COVID-19 vaccine from Moderna.

article thumbnail

Researchers ‘must embrace the change’ in the year ahead: PRA

Outsourcing Pharma

The head of the CROâs Global Center of Excellence for Decentralized Clinical Trial Strategy outlines key developments in 2020, and keys to success in 2021.

article thumbnail

COVID-19 Vaccine Rollout Glitches: Extra Doses, Supply Chain, Snowstorm and Anaphylaxis

BioSpace

As Pfizer-BioNTech and the U.S. government begin the historic rollout of COVID-19 vaccine distribution around the U.S. and the world, there have been a few glitches. This isn’t unexpected.

article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

NICE recommends Novartis’ wet AMD drug Beovu

Pharma Times

Final appraisal determination recommends anti-VEGF treatment for NHS use

Drugs 132
article thumbnail

A Bright Day for Two Companies as New CEOs Announced

BioSpace

On Wednesday, Sage Therapeutics and Samsung Biologics announced that they had found just that in their new chief executive officers.

102
102
article thumbnail

New research reveals impact of childhood type 1 diabetes on mental health

Pharma Times

Surveys uncovers findings pre- and post-pandemic

Research 147
article thumbnail

Neuro Biotech Scooped Up by Novartis in $770 Million Deal

BioSpace

Novartis is acquiring Cambridge, Massachusetts-based Cadent Therapeutics for $210 million up front and a possible $560 million in milestone payments.

98
article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

Study finds big differences between top symptom checker apps

pharmaphorum

Apps that patients can use to report symptoms and seek advice on treatment are highly variable in their accuracy, but some come close to matching GPs, says a new study. The peer-reviewed study – published in the journal BMJ Open – compared eight of the most popular symptom assessment apps to a control group of seven GPs against a series of 200 primary care scenarios or “vignettes” designed to mimic real-world patient experiences and gleaned from the NHS 111 telephone triage service.

Doctors 80
article thumbnail

AstraZeneca Closes in on Potential UK Vaccine Authorization and Other COVID-19 News

BioSpace

Despite some setbacks, the company anticipates its vaccine could be available for use in the United Kingdom within the next several weeks.

article thumbnail

Looking back, thinking ahead: industry leaders talk trends

Outsourcing Pharma

Experts from a variety of research and drug development organizations share their thoughts on highlights from 2020, and predict what 2021 might hold.

article thumbnail

Thermo Fisher Invests in Gene Therapy Future with Huge Expansions

BioSpace

The company is significantly expanding its footprint with new facilities in the United States and in Europe.

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

2020 was ‘the year our industry got it right’: pharma veteran

Outsourcing Pharma

William Carson says while the past year was full of challenges, embracing AI and other advanced technology led to impressive progress and opportunity.

article thumbnail

Global Roundup: Russian Vaccine Posts 90% Efficacy, RDIF Says

BioSpace

Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

article thumbnail

Data explosion leads to opportunities, obstacles: ACD/Labs

Outsourcing Pharma

A representative from the small-molecule solutions company explains how the ever-increasing mountain of life-sciences data has impacted drug development.

article thumbnail

Building Better Virus Countermeasures — J&J’s BLUE KNIGHT™ Symposium Shows What’s Coming

BioSpace

With the first wave of vaccines gaining regulatory approval, nascent biotech companies are looking toward the future, exploring new technologies to make vaccines more effective for more people.

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.

article thumbnail

New patent for Nalpropion drug CONTRAVE

Drug Patent Watch

Annual Drug Patent Expirations for CONTRAVE Contrave is a drug marketed by Nalpropion and is included in one NDA. It is available from three suppliers. There are twelve patents protecting…. The post New patent for Nalpropion drug CONTRAVE appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 59
article thumbnail

A non-destructive method for analyzing Ancient Egyptian embalming materials

Scienmag

Credit: Frédérique Vincent, ethnographic conservator Ancient Egyptian mummies have many tales to tell, but unlocking their secrets without destroying delicate remains is challenging. Now, researchers reporting in ACS’ Analytical Chemistry have found a non-destructive way to analyze bitumen — the compound that gives mummies their dark color — in Ancient Egyptian embalming materials.

article thumbnail

How pharma needs to change for the era of digital health

pharmaphorum

Experts from Healthware Group explore how companies can rebuild their approach to digital from the ground up for the benefit of patients. Digital is not just a nice-to-have for pharma companies – it’s a necessity for ensuring that patients have the best possible outcomes in modern healthcare systems. With digital tools and techniques being able to improve almost every aspect of a pharma company’s business, from R&D to sales, there’s no excuse for not implementing digital transformation at ev

article thumbnail

Which Types of Continued Learning Can You List on a Resume?

BioSpace

While continued learning opportunities are easy to access and many are quite affordable, the real question is, can you list these courses on your resume? And if you do so, what will recruiters in the biotech field think of them?

90
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.